Not applicableActive Not RecruitingNCT07704801What this trial is testingCDK4/6 Inhibitors in Metastatic HR-Positive Breast CancerWho this might be right forMetastatic Breast Cancer Sohag University 300
Not applicableUnknownNCT05020522What this trial is testingComparison of Diagnostic Accuracy of Luminal Index and MP MRI for Accelerated deTEction of Significant Prostate CancerWho this might be right forProstate Cancer University College, London 702
Large-scale testing (Phase 3)Active Not RecruitingNCT04134598What this trial is testingExclUsive endocRine Therapy Or Radiation theraPy for Women Aged ≥70 Years Early Stage Breast CancerWho this might be right forBreast Cancer Azienda Ospedaliero-Universitaria Careggi 926
Testing effectiveness (Phase 2)Looking for participantsNCT07016399What this trial is testingNeoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBCWho this might be right forAnatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Triple-Negative Breast Carcinoma Vandana Abramson 51
Not applicableEnded earlyNCT01590394What this trial is testingPatency of a Prototype Large Plastic Biliary Stent in the Palliation of Malignant Distal Biliary Strictures.Who this might be right forStrictureObstructionCancer Mayo Clinic 3
Testing effectiveness (Phase 2)WithdrawnNCT02140437What this trial is testingFulvestrant Combined Anastrozole Versus Anastrozole in Luminal A-like Postmenopausal ABCWho this might be right forCarcinoma Breast Stage IV Fudan University
Not applicableStudy completedNCT01954862What this trial is testingComparison of Methods to Distend the Colon During Insertion: CO2, Air Insufflation, Water-aided ColonoscopyWho this might be right forPainColorectal AdenomasColorectal Cancer Presidio Ospedaliero Santa Barbara 624
Large-scale testing (Phase 3)Not Yet RecruitingNCT07760844What this trial is testingAn Open-Label, Randomized Phase III Study of Trastuzumab Rezetecan With or Without Everolimus in First to Third Line LAR Subtype TNBCWho this might be right forBreast CancerTriple Negative Breast Cancer (TNBC) Fudan University 180
Testing effectiveness (Phase 2)Active Not RecruitingNCT03917082What this trial is testingLimited Adjuvant Endocrine Therapy for Low Risk Breast CancerWho this might be right forBreast Cancer FemaleHormone Receptor Positive Tumor British Columbia Cancer Agency 290
Not applicableStudy completedNCT03266835What this trial is testingSoundBite™ Crossing System Pivotal Peripheral CTO Crossing StudyWho this might be right forChronic Total Occlusion of Arteries of the Extremities SoundBite Medical Solutions, Inc. 15
Large-scale testing (Phase 3)WithdrawnNCT06585969What this trial is testingA Randomised Trial Comparing Trastuzumab Deruxtecan to CDK4/6 Inhibitors in Non-luminal A, ER-positive/HER2-low Metastatic Breast CancerWho this might be right forMetastatic Breast CancerER-positive Breast CancerLuminal B+2 more Danish Breast Cancer Cooperative Group
Very early researchStudy completedNCT02802748What this trial is testingPhase 0 Study of Metronomic Oral Vinorelbine and Letrozole in HR+/HER2-negative Early Breast Cancer Patients (VENTANA)Who this might be right forBreast Cancer SOLTI Breast Cancer Research Group 60
Not applicableStudy completedNCT04540224What this trial is testingThe Relationship Between the Differences in Blood Cytokine Values in Breast Cancers.Who this might be right forBreast Cancer Istanbul Training and Research Hospital 78
Testing effectiveness (Phase 2)Active Not RecruitingNCT04759248What this trial is testingStudy With Atezolizumab in Combination With Trastuzumab and Vinorelbine in HER2-positive Advanced/Metastatic Breast CancerWho this might be right forBreast Cancer SOLTI Breast Cancer Research Group 55
Testing effectiveness (Phase 2)Active Not RecruitingNCT02603679What this trial is testingNeoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node MetastasesWho this might be right forEarly-Stage Breast CarcinomaEstrogen Receptor Positive Tumor Thomas Hatschek 181
Testing effectiveness (Phase 2)Looking for participantsNCT06486883What this trial is testingSafety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal SubtypeWho this might be right forAdvanced Breast CancerAdvanced Breast CarcinomaHormone Receptor Positive Breast Carcinoma MedSIR 200
Large-scale testing (Phase 3)Study completedNCT01950182What this trial is testingTrastuzumab Combined With Chemotherapy or Endocrine Therapy to Treat Metastatic Luminal B2 Breast CancerWho this might be right forBreast Cancer Sun Yat-sen University 392
Not applicableStudy completedNCT02856763What this trial is testingPredictive Factors of ANTI-TNF Response in Luminal Crohn's Disease Complicated by AbscessWho this might be right forCD Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives 125
Not applicableLooking for participantsNCT06590506What this trial is testingHigh Definition Medicine for Solid Tumors OncologyWho this might be right forMetastatic Solid TumorAdvanced Cancer Centro Nacional de Investigaciones Oncologicas CARLOS III 300
Large-scale testing (Phase 3)Study completedNCT01314833What this trial is testingMinus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer TherapyWho this might be right forPrimary Breast Cancer Fudan University 1,570